WUXIBODY Trademark

Trademark Overview

On Tuesday, December 26, 2017, a trademark application was filed for WUXIBODY with the United States Patent and Trademark Office. The USPTO has given the WUXIBODY trademark a serial number of 87734294. The federal status of this trademark filing is REGISTERED as of Tuesday, December 21, 2021. This trademark is owned by WuXi AppTec Biopharmaceuticals Co., Ltd.. The WUXIBODY trademark is filed in the Pharmaceutical Products category with the following description:

Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations, namely, therapeutic antibody drug containing a bispecific antibody formulation which can be used to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders; Biological preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Disinfectants for hygiene purposes; Chewing gum for medical purposes; Nutritional supplements
wuxibody

General Information

Serial Number87734294
Word MarkWUXIBODY
Filing DateTuesday, December 26, 2017
Status700 - REGISTERED
Status DateTuesday, December 21, 2021
Registration Number6598098
Registration DateTuesday, December 21, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements

Description of MarkThe mark consists of the stylized wording "WUXIBODY" with the wording "WUXI" in blue. There is a blue curved line under the wording "WUXI" and a green curved line above the wording "WUXI". The dot in the letter "I" is depicted as a diamond shape in the color green, also forming the tip of the green curved line. To the right of the wording "WUXI" is the stylized wording "BODY", with the letters "BOD" in the color green and the "Y" made up of two intersecting, curved band elements, one in the color green and one in the color blue.
Goods and ServicesPrescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations, namely, therapeutic antibody drug containing a bispecific antibody formulation which can be used to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders; Biological preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Disinfectants for hygiene purposes; Chewing gum for medical purposes; Nutritional supplements
Indication of Colors claimedThe colors blue and green are claimed as a feature of the mark.
Translation of Words in MarkThe wording "WUXIBODY" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 11, 2018
Primary Code005
First Use Anywhere DateTuesday, June 11, 2019
First Use In Commerce DateFriday, May 14, 2021

Trademark Owner History

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressDUNDALK, COUNTY LOUTH A91 X56F
IE
Party NameWuXi AppTec Biopharmaceuticals Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMashan, WuXi, 214092
CN
Party NameWuXi AppTec Biopharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMashan, WuXi, 214092
CN
Party NameWuXi AppTec Biopharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMashan, WuXi, 214092
CN

Trademark Events

Event DateEvent Description
Wednesday, June 1, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 25, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 21, 2021REGISTERED-PRINCIPAL REGISTER
Friday, November 19, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, November 18, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 18, 2021ASSIGNED TO LIE
Monday, November 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 2, 2021NON-FINAL ACTION E-MAILED
Friday, July 2, 2021SU - NON-FINAL ACTION - WRITTEN
Friday, June 25, 2021STATEMENT OF USE PROCESSING COMPLETE
Monday, June 21, 2021USE AMENDMENT FILED
Monday, June 21, 2021TEAS STATEMENT OF USE RECEIVED
Friday, April 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 23, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 11, 2021SOU EXTENSION 5 GRANTED
Thursday, January 7, 2021SOU EXTENSION 5 FILED
Thursday, January 7, 2021TEAS EXTENSION RECEIVED
Thursday, July 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 21, 2020SOU EXTENSION 4 GRANTED
Tuesday, July 21, 2020SOU EXTENSION 4 FILED
Tuesday, July 21, 2020TEAS EXTENSION RECEIVED
Wednesday, January 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 20, 2020SOU EXTENSION 3 GRANTED
Monday, January 20, 2020SOU EXTENSION 3 FILED
Monday, January 20, 2020TEAS EXTENSION RECEIVED
Saturday, July 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 11, 2019SOU EXTENSION 2 GRANTED
Thursday, July 11, 2019SOU EXTENSION 2 FILED
Thursday, July 11, 2019TEAS EXTENSION RECEIVED
Wednesday, March 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 20, 2019CORRECTED NOA E-MAILED
Tuesday, March 19, 2019SOU EXTENSION 1 GRANTED
Monday, January 21, 2019SOU EXTENSION 1 FILED
Tuesday, March 19, 2019DIVISIONAL PROCESSING COMPLETE
Sunday, January 21, 2018DIVISIONAL REQUEST RECEIVED
Monday, January 21, 2019TEAS REQUEST TO DIVIDE RECEIVED
Friday, March 1, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 5, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, January 21, 2019TEAS EXTENSION RECEIVED
Tuesday, July 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 25, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 24, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, April 24, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 24, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, April 24, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 11, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, April 11, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 11, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, April 11, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, April 6, 2018ASSIGNED TO EXAMINER
Friday, January 12, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, January 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 29, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

wuxibody disease autoimmune coagulation infectious diseases preparations disorder antibody namely drug